Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -188.25% is 13% below its 2-year average of -166.75%, near the low end of its 2-year range (-254.05%–2.77%).
19.13% below its 12-month average of -158.02%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -208.07%.
OPERATING MARGIN
-188.25%
OPERATING MARGIN AVG TTM
-158.02%
OPERATING MARGIN AVG 3Y
N/A
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-19.13%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 556 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
CapsoVision, Inc.
Market Cap
$323.01M
Operating Margin
-188.25%
TTM Avg
-158.02%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$316.53M
Operating Margin
-144.71%
TTM Avg
-144.71%
3Y Avg
-144.71%
5Y Avg
-144.71%
Market Cap
$328.40M
Operating Margin
-290.68%
TTM Avg
-313.41%
3Y Avg
-428.31%
5Y Avg
-345.79%
Market Cap
$329.37M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$309.26M
Operating Margin
-109.34%
TTM Avg
-104.90%
3Y Avg
-100.12%
5Y Avg
-81.51%
Market Cap
$304.88M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-6360.33%
5Y Avg
-12157.15%
Market Cap
$341.50M
Operating Margin
0.00%
TTM Avg
-13402.79%
3Y Avg
-7027.62%
5Y Avg
-5128.57%
Market Cap
$341.46M
Operating Margin
-65.36%
TTM Avg
-64.13%
3Y Avg
-75.36%
5Y Avg
-72.00%
Market Cap
$348.55M
Operating Margin
-18.00%
TTM Avg
-67.22%
3Y Avg
-104.89%
5Y Avg
-90.63%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CapsoVision, Inc. (CV) | $323.01M | -188.25% | -158.02% | N/A | N/A |
| Mobia Medical, Inc. Common Stock (MOBI)vs › | $316.53M | -144.71% | -144.71% | -144.71% | -144.71% |
| C4 Therapeutics, Inc. (CCCC)vs › | $328.40M | -290.68% | -313.41% | -428.31% | -345.79% |
| Cabaletta Bio, Inc. (CABA)vs › | $329.37M | 0.00% | 0.00% | 0.00% | 0.00% |
| Standard BioTools Inc. (LAB)vs › | $309.26M | -109.34% | -104.90% | -100.12% | -81.51% |
| Benitec Biopharma Inc. (BNTC)vs › | $304.88M | 0.00% | 0.00% | -6360.33% | -12157.15% |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $341.50M | 0.00% | -13402.79% | -7027.62% | -5128.57% |
| ClearPoint Neuro, Inc. (CLPT)vs › | $341.46M | -65.36% | -64.13% | -75.36% | -72.00% |
| Agenus Inc. (AGEN)vs › | $348.55M | -18.00% | -67.22% | -104.89% | -90.63% |
| Embecta Corp. (EMBC)vs › | $354.48M | 24.85% | 23.00% | 24.99% | 31.17% |
Gross Margin
50.9%
Operating Margin
-188.3%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -208.07% |
| 2026-03-31 | -254.05% |
| 2025-12-31 | -190.45% |
| 2025-09-30 | 2.77% |
| 2025-06-30 | -140.30% |
| 2025-03-31 | -193.39% |
| 2024-12-31 | -134.24% |
| 2024-09-30 | -195.65% |
| 2024-06-30 | -185.40% |
| 2024-03-31 | -168.74% |
